Ochre Bio co-founder and CSO Quin Wills spoke with In Vivo about the UK-based company's novel approach to finding and validating RNA therapies for chronic liver diseases.

Precision Medicine in Liver Treatment: The Ochre Bio Approach

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Share Precision Medicine in Liver Treatment: The Ochre Bio Approach

Sign up to save your podcasts

Precision Medicine in Liver Treatment: The Ochre Bio Approach

Precision Medicine in Liver Treatment: The Ochre Bio Approach

More shows like Citeline Podcasts

The Documentary Podcast

Nature Podcast

Economist Podcasts

Marketplace

Marketplace All-in-One

Exchanges

Decoder with Nilay Patel

The Long Run with Luke Timmerman

The Readout Loud

FT News Briefing

The Intelligence from The Economist

The Rachman Review

BioCentury This Week

Biotech Hangout

Money Stuff: The Podcast